Interferon-γ, interleukins-6 and -4, and factor XIII-A as indirect markers of the classical and alternative macrophage activation pathways in chronic periodontitis

Journal of Periodontology

Volumn 85, Issue 5, 2014, Pages 751-760

  Navarrete, Mariely ^a   García, Jocelyn ^b   Dutzan, Nicolás ^b   Henríquez, Leslie ^b   Puente, Javier ^b   Carvajal, Paola ^b   Hernandez, Marcela ^b   Gamonal, Jorge ^b  

^a UNIVERSIDAD ANDRÉS BELLO   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Cytokines; Factor XIII; Immunology; Macrophage activation; Macrophages; Periodontal diseases

Indexed keywords

ACTIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 13A; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON; IL4 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 4; INTERLEUKIN 6; LEUKOCYTE ANTIGEN;

ADULT; ALVEOLAR BONE LOSS; BIOPSY; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; TOOTH PLAQUE; WESTERN BLOTTING;

ACTINS; ADULT; ALVEOLAR BONE LOSS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; BIOPSY; BLOTTING, WESTERN; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XIIIA; FEMALE; GINGIVA; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-4; INTERLEUKIN-6; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET;

EID: 84901431922     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.130078     Document Type: Article

References (45)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Chomyszyn-Gajewska M, Czajkowska B, Blazewicz M, Pamula E, Ptak M. In vitro response of macrophages to a new carbon-polylactide composite for the treatment of periodontal diseases. Biomaterials 2002;23:463-470.
3. Ali H, Haribabu B, Richardson RM, Snyderman R. Mechanisms of inflammation and leukocyte activation. Med Clin North Am 1997;81:1-28. (Pubitemid 27043793)
4. Gratchev A, Guillot P, Hakiy N, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 2001;53:386-392. (Pubitemid 32275696)
5. Page RC. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodontal Res 1991;26:230-242.
6. Mosser DM. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-212. (Pubitemid 36158295)
7. Duffield JS. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003;104:27-38. (Pubitemid 36249921)
8. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)
9. Correa Duque M. Alternative macrophage activation: The diversity of one cell involved in innate immunity in response to its environmenytal complexity (in Spanish). Inmunología 2007;26:73-86.
10. Gordon S, Martinez FO. Alternative activation of macrophages: Mechanism and functions. Immunity 2010; 32:593-604.
11. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005;23: 901-944. (Pubitemid 40563189)
12. Töröcsik D, Bárdos H, Nagy L, Adány R. Identification of factor XIII-A as a marker of alternative macrophage activation. Cell Mol Life Sci 2005;62:2132-2139.
13. Muszbek L, Adány R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996;33: 357-421.
14. Asahina T, Kobayashi T, Okada Y, Goto J, Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000;21:388-393. (Pubitemid 30364873)
15. Lorand L. Factor XIII and the clotting of fibrinogen: From basic research to medicine. J Thromb Haemost 2005;3:1337-1348. (Pubitemid 41725185)
16. Herrera D, Contreras A, Gamonal J, et al. Subgingival microbial profiles in chronic periodontitis patients from Chile, Colombia and Spain. J Clin Periodontol 2008; 35:106-113.
17. Ramfjord SP, Nissle RR. The modified widman flap. J Periodontol 1974;45:601-607.
18. Atkinson K, Munro V, Vasak E, Biggs J. Mononuclear cell subpopulations in the skin defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. Br J Dermatol 1986;114:145-160. (Pubitemid 16131421)
19. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 2001;36:194-203. (Pubitemid 33643505)
20. Chapple CC, Srivastava M, Hunter N. Failure of macrophage activation in destructive periodontal disease. J Pathol 1998;186:281-286. (Pubitemid 28494356)
21. Schlegel Gómez R, Langer P, Pelka M, von den Driesch P, Johannessen AC, Simon M Jr. Variational expression of functionally different macrophage markers (27E10, 25F9, RM3/1) in normal gingiva and inflammatory periodontal disease. J Clin Periodontol 1995; 22:341-346.
22. Ralph VF. Mononuclear phagocyte system. In: Peter JD, ed. Encyclopedia of Immunology, 2nd ed. Oxford, UK: Elsevier; 1998:1755-1758.
23. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madaliński K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol 2003;30: 1046-1052.
24. Garlet GP, Martins W Jr., Ferreira BR, Milanezi CM, Silva JS. Patterns of chemokines and chemokine receptors expression in different forms of human periodontal disease. J Periodontal Res 2003;38:210-217. (Pubitemid 37485621)
25. + Th-cell-mediated alveolar bone destruction in vivo. Infect Immun 2005;73: 3453-3461. (Pubitemid 40745889)
26. Repeke CE, Ferreira SB Jr., Claudino M, et al. Evidences of the cooperative role of the chemokines CCL3, CCL4 and CCL5 and its receptors CCR1+ and CCR5+ in RANKL+ cell migration throughout experimental periodontitis in mice. Bone 2010;46:1122-1130.
27. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: Consensus and issues. Cytometry A 2008;73:975-983.
28. Salvi GE, Brown CE, Fujihashi K, et al. Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 1998;33:212-225. (Pubitemid 128527149)
29. Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000 2004;35:21-41. (Pubitemid 41742817)
30. Nichols FC, Garrison SW. Interferon-gamma potentiation of lipopolysaccharide-induced eicosanoid release from human monocytes. J Interferon Res 1987;7:121-129. (Pubitemid 17154703)
31. Rodriguez MC. Quantification of periodontal tissue interleukin 6. J Fund Juan José Carraro 2005;10:9-18.
32. Kono Y, Beagley KW, Fujihashi K, et al. Cytokine regulation of localized inflammation. Induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in inflamed human gingiva. J Immunol 1991; 146:1812-1821.
33. Reinhardt RA, Masada MP, Kaldahl WB, et al. Gingival fluid IL-1 and IL-6 levels in refractory periodontitis. J Clin Periodontol 1993;20:225-231.
34. Kurtisx B, Develioǵlu H, Taner IL, Balosx K, Tekin IO. IL-6 levels in gingival crevicular fluid (GCF) from patients with non-insulin dependent diabetes mellitus (NIDDM), adult periodontitis and healthy subjects. J Oral Sci 1999;41:163-167.
35. Lee JD, Rhoades K, Economou JS. Interleukin-4 inhibits the expression of tumour necrosis factors alpha and beta, interleukins-1 beta and -6 and interferongamma. Immunol Cell Biol 1995;73:57-61.
36. Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1988;141:1529-1535.
37. Geivelis M, Turner DW, Pederson ED, Lamberts BL. Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 1993;64:980-983.
38. Pradeep AR, Roopa Y, Swati PP. Interleukin-4, a T-helper 2 cell cytokine, is associated with the remission of periodontal disease. J Periodontal Res 2008;43:712-716.
39. Napimoga MH, Nunes LH, Maciel AA, et al. Possible involvement of IL-21 and IL-10 on salivary IgA levels in chronic periodontitis subjects. Scand J Immunol 2011; 74:596-602.
40. Mangan DF, Robertson B, Wahl SM. IL-4 enhances programmed cell death (apoptosis) in stimulated human monocytes. J Immunol 1992;148:1812-1816.
41. Shapira L, van Dyke TE, Hart TC. A localized absence of interleukin-4 triggers periodontal disease activity: A novel hypothesis. Med Hypotheses 1992;39:319-322. (Pubitemid 23010768)
42. Holla LI, Fassmann A, Augustin P, Halabala T, Znojil V, Vanek J. The association of interleukin-4 haplotypes with chronic periodontitis in a Czech population. J Periodontol 2008;79:1927-1933.
43. Mattuella LG, Campagnaro MB, Vargas AE, et al. Plasma cytokines levels in aggressive and chronic periodontitis. Acta Odontol Scand 2013;71:683-686.
44. Johnson RB, Serio FG. The contribution of interleukin-13 and -15 to the cytokine network within normal and diseased gingiva. J Periodontol 2007;78:691-695.
45. Hallam S, Escorcio-Correia M, Soper R, Schultheiss A, Hagemann T. Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NFkappaB. J Pathol 2009;219:143-152. Development